[1] Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A, et al. Oral mucositis: the hidden side of cancer therapy. Journal of experimental & clinical cancer research. 2020;39:210. https://doi.org/10.1186/s13046-020-01715-7.
[2] Shetty SS, Maruthi M, Dhara V, de Arruda JA, Abreu LG, Mesquita RA, et al. Oral mucositis: Current knowledge and future directions. Disease-a-Month. 2022;68(5):101300. https://doi.org/10.1016/j.disamonth.2021.101300.
[3] Kitagawa J, Kobayashi R, Nagata Y, Kasahara S, Ono T, Sawada M, et al. Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial. International Journal of Cancer. 2021;148(6):1462-9. https://doi.org/10.1002/ijc.33316.
[4] Hewlings S, Kalman D. A review of zinc-L-carnosine and its positive effects on oral mucositis, taste disorders, and gastrointestinal disorders. Nutrients. 2020;12(3):665. https://doi.org/10.3390/nu12030665.
[5] Elad S, Yarom N, Zadik Y, Kuten‐Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA: a cancer journal for clinicians. 2022;72(1):57-77. https://doi.org/10.3322/caac.21704.
[6] Cesak O, Vostalova J, Vidlar A, Bastlova P, Student Jr V. Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment. Nutrients. 2023;15(7):1770. https://doi.org/10.3390/nu15071770.
[7] Tsubura-Okubo M, Komiyama Y, Kamimura R, Sawatani Y, Arai H, Mitani K, et al. Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients. International Journal of Oral and Maxillofacial Surgery. 2021;50(7):906-14. https://doi.org/10.1016/j.ijom.2020.10.004.
[8] Lee CT, Galloway TJ. Pathogenesis and amelioration of radiation-induced oral mucositis. Current Treatment Options in Oncology. 2022;23(3):311-24. https://doi.org/10.1007/s11864-022-00959-z.
[9] Ana GS, Normando AG, de Toledo IP, Dos Reis PE, Guerra EN. Topical treatment of oral mucositis in cancer patients: a systematic review of randomized clinical trials. Asian Pacific Journal of Cancer Prevention: APJCP. 2020;21(7):1851-66. https://doi.org/10.31557%2FAPJCP.2020.21.7.1851.
[10] Elad S, Cheng KK, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423-31. https://doi.org/10.1002/cncr.33100.
[11] Tang W, Liu H, Ooi TC, Rajab NF, Cao H, Sharif R. Zinc carnosine: Frontiers advances of supplement for cancer therapy. Biomedicine & Pharmacotherapy. 2022;151:113157. https://doi.org/10.1016/j.biopha.2022.113157.
[12] Efthymakis K, Neri M. The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clinics and Research in Hepatology and Gastroenterology. 2022;46(7):101954. https://doi.org/10.1016/j.clinre.2022.101954.
[13] Mohammadi F, Oshvandi K, Kamallan SR, Khazaei S, Ranjbar H, Ahmadi‐Motamayel F, et al. Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy. Nursing Open. 2022;9(3):1602-11. https://doi.org/10.1002/nop2.1168.
[14] Mehdipour M, Zenoz AT, Kermani IA, Hosseinpour A. A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2011;19(1):71-3.
[15] Mosalaei A, Nasrolahi H, Shafizad A, Ahmadloo N, Ansari M, Shirazi MA, et al. Effect of Oral Zinc Sulphate in Prevention of Radiation Induced Oropharyngeal Mucositis During and After Radiotherapy in Patients with Head and Neck Cancers. Middle East Journal of Cancer 2010;1(2): 69-76.